BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23850490)

  • 21. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.
    Yu H; Mashtalir N; Daou S; Hammond-Martel I; Ross J; Sui G; Hart GW; Rauscher FJ; Drobetsky E; Milot E; Shi Y; Affar el B
    Mol Cell Biol; 2010 Nov; 30(21):5071-85. PubMed ID: 20805357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.
    Mashtalir N; Daou S; Barbour H; Sen NN; Gagnon J; Hammond-Martel I; Dar HH; Therrien M; Affar el B
    Mol Cell; 2014 May; 54(3):392-406. PubMed ID: 24703950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAP1 links metabolic regulation of ferroptosis to tumour suppression.
    Zhang Y; Shi J; Liu X; Feng L; Gong Z; Koppula P; Sirohi K; Li X; Wei Y; Lee H; Zhuang L; Chen G; Xiao ZD; Hung MC; Chen J; Huang P; Li W; Gan B
    Nat Cell Biol; 2018 Oct; 20(10):1181-1192. PubMed ID: 30202049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1.
    Lee SW; Cho YS; Na JM; Park UH; Kang M; Kim EJ; Um SJ
    J Biol Chem; 2010 Jan; 285(1):18-29. PubMed ID: 19880879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of the tumor suppressor BAP1 causes myeloid transformation.
    Dey A; Seshasayee D; Noubade R; French DM; Liu J; Chaurushiya MS; Kirkpatrick DS; Pham VC; Lill JR; Bakalarski CE; Wu J; Phu L; Katavolos P; LaFave LM; Abdel-Wahab O; Modrusan Z; Seshagiri S; Dong K; Lin Z; Balazs M; Suriben R; Newton K; Hymowitz S; Garcia-Manero G; Martin F; Levine RL; Dixit VM
    Science; 2012 Sep; 337(6101):1541-6. PubMed ID: 22878500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes.
    Arenzana TL; Lianoglou S; Seki A; Eidenschenk C; Cheung T; Seshasayee D; Hagenbeek T; Sambandam A; Noubade R; Peng I; Lesch J; DeVoss J; Wu X; Lee WP; Caplazi P; Webster J; Liu J; Pham VC; Arnott D; Lill JR; Modrusan Z; Dey A; Rutz S
    Sci Immunol; 2018 Apr; 3(22):. PubMed ID: 29678836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PR-DUB maintains the expression of critical genes through FOXK1/2- and ASXL1/2/3-dependent recruitment to chromatin and H2AK119ub1 deubiquitination.
    Kolovos P; Nishimura K; Sankar A; Sidoli S; Cloos PA; Helin K; Christensen J
    Genome Res; 2020 Aug; 30(8):1119-1130. PubMed ID: 32747411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics.
    Abdel-Wahab O; Dey A
    Leukemia; 2013 Jan; 27(1):10-5. PubMed ID: 23147254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia.
    Wang L; Birch NW; Zhao Z; Nestler CM; Kazmer A; Shilati A; Blake A; Ozark PA; Rendleman EJ; Zha D; Ryan CA; Morgan MAJ; Shilatifard A
    Nat Cancer; 2021 May; 2(5):515-526. PubMed ID: 35122023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BAP1/ASXL complex modulation regulates epithelial-mesenchymal transition during trophoblast differentiation and invasion.
    Perez-Garcia V; Lea G; Lopez-Jimenez P; Okkenhaug H; Burton GJ; Moffett A; Turco MY; Hemberger M
    Elife; 2021 Jun; 10():. PubMed ID: 34170818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
    Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
    Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
    Webster JD; Pham TH; Wu X; Hughes NW; Li Z; Totpal K; Lee HJ; Calses PC; Chaurushiya MS; Stawiski EW; Modrusan Z; Chang MT; Tran C; Lee WP; Chalasani S; Hung J; Sharma N; Chan S; Hotzel K; Talevich E; Shain A; Xu M; Lill J; Dixit VM; Bastian BC; Dey A
    Pigment Cell Melanoma Res; 2019 Mar; 32(2):269-279. PubMed ID: 30156010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular mechanisms by which the mutant ASXL1/BAP1 complex aggravates myeloid leukemia].
    Asada S
    Rinsho Ketsueki; 2020; 61(4):392-405. PubMed ID: 32378586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors.
    Sacco JJ; Kenyani J; Butt Z; Carter R; Chew HY; Cheeseman LP; Darling S; Denny M; Urbé S; Clague MJ; Coulson JM
    Oncotarget; 2015 May; 6(15):13757-71. PubMed ID: 25970771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms.
    Asada S; Kitamura T
    Int J Hematol; 2019 Aug; 110(2):179-186. PubMed ID: 30515738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion.
    Shen C; Wang Y; Wei P; Du X
    BMC Cancer; 2016 Aug; 16(1):670. PubMed ID: 27553041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.
    Okino Y; Machida Y; Frankland-Searby S; Machida YJ
    J Biol Chem; 2015 Jan; 290(3):1580-91. PubMed ID: 25451922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder.
    Küry S; Ebstein F; Mollé A; Besnard T; Lee MK; Vignard V; Hery T; Nizon M; Mancini GMS; Giltay JC; Cogné B; McWalter K; Deb W; Mor-Shaked H; Li H; Schnur RE; Wentzensen IM; Denommé-Pichon AS; Fourgeux C; Verheijen FW; Faurie E; Schot R; Stevens CA; Smits DJ; Barr E; Sheffer R; Bernstein JA; Stimach CL; Kovitch E; Shashi V; Schoch K; Smith W; van Jaarsveld RH; Hurst ACE; Smith K; Baugh EH; Bohm SG; Vyhnálková E; Ryba L; Delnatte C; Neira J; Bonneau D; Toutain A; Rosenfeld JA; ; Audebert-Bellanger S; Gilbert-Dussardier B; Odent S; Laumonnier F; Berger SI; Smith ACM; Bourdeaut F; Stern MH; Redon R; Krüger E; Margueron R; Bézieau S; Poschmann J; Isidor B
    Am J Hum Genet; 2022 Feb; 109(2):361-372. PubMed ID: 35051358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A common ancestry for BAP1 and Uch37 regulators.
    Sanchez-Pulido L; Kong L; Ponting CP
    Bioinformatics; 2012 Aug; 28(15):1953-6. PubMed ID: 22645167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An emerging model for BAP1's role in regulating cell cycle progression.
    Eletr ZM; Wilkinson KD
    Cell Biochem Biophys; 2011 Jun; 60(1-2):3-11. PubMed ID: 21484256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.